BHVN — Biohaven Cashflow Statement
0.000.00%
Last trade - 00:00
- $4.56bn
- $4.18bn
- 29
- 13
- 90
- 40
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -119 | -214 | -570 | -408 |
Depreciation | ||||
Non-Cash Items | 33.7 | 64.9 | 300 | 44.9 |
Equity in Net Earnings/Losses | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 8.98 | 1.66 | -28.6 | 24.6 |
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Other Liabilities | ||||
Cash from Operating Activities | -76 | -146 | -298 | -332 |
Capital Expenditures | -2.7 | -0.938 | -6.07 | -3.05 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | 0 | 1.88 | -299 | 133 |
Acquisition of Business | ||||
Sale of Business | ||||
Sale/Maturity of Investment | ||||
Purchase of Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -2.7 | 0.944 | -305 | 130 |
Financing Cash Flow Items | 152 | 138 | 484 | -31.3 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Cash from Financing Activities | 152 | 138 | 768 | 212 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 73.6 | -6.45 | 166 | 9.52 |